[1]
Shved, M.I. and Ovsiichuk, R.M. 2022. EFFECTIVENESS OF DYSLIPIDEMIA AND PRO-OXIDANT-ANTIOXIDANT BALANCE CORRECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME ON THE BACKGROUND OF TYPE 2 DIABETES WITH SGLT2 INHIBITOR – DAPAGLIFLOZIN. Medical and Clinical Chemistry. 3 (Dec. 2022), 18–26. DOI:https://doi.org/10.11603/mcch.2410-681X.2022.i3.13360.